Delivery Order SPE2DB24D1205-SPE2DB24FCTFJ

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $63K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Humira (adalimumab) medication. The contract is a firm-fixed-price delivery order with a ceiling value of $10,143.07 and a period of performance through January 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Humira (adalimumab) pharmaceutical medication. The contract has a ceiling value of $8,417.97 and a period of performance through October 16, 2024. This contract is not set aside for small businesses or other socioeconomic categories. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (adalimumab), a prescription medication used to treat various autoimmune conditions. The contract has a ceiling value of $43,341.96 and a period of performance through April 30, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (Adalimumab) medication. The contract has a ceiling value of $15,136.80 and a period of performance through December 12, 2023. It is a firm-fixed-price contract type, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $93,641.68, is for the supply of Humira (adalimumab) medication. It is a firm fixed-price delivery order contract with a completion date of February 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (Adalimumab) medication, a specialty biologic drug used to treat various autoimmune conditions. The contract has a firm fixed price of $9,526.07 and a ceiling value of up to that amount. The delivery order is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) medication. The contract has a firm fixed price of $3,647.40 and a performance period ending on April 9, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) medication. The contract has a firm fixed price of $3,850.69 and a period of performance through May 12, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,738.72, is for the supply of Humira (adalimumab) medication, a biologic drug used to treat autoimmune diseases. The contract is a firm-fixed-price, non-set-aside award with a period of performance through April 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira (CF) 40 mg/0.4 mL medication, with a ceiling value of $5,811.50 and a performance period through April 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCTFJ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Humira (adalimumab) pharmaceutical products. The contract has a ceiling value of $63,074.49 and a performance period ending on July 31, 2024. The contract is a firm-fixed-price type and is not designated as a set-aside for any specific business category. Amerisourcebergen, a major pharmaceutical distributor, will provide the Humira products to support the medical needs of military treatment facilities, veterans' hospitals, and other federal healthcare providers under this contract. This award is likely part of a broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, which enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from the company.

Generated 10/29/24, 9:22 AM